17.75
price down icon1.17%   -0.21
after-market After Hours: 17.90 0.15 +0.85%
loading
Caredx Inc stock is traded at $17.75, with a volume of 580.26K. It is down -1.17% in the last 24 hours and down -19.86% over the past month. CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$17.96
Open:
$17.32
24h Volume:
580.26K
Relative Volume:
0.74
Market Cap:
$986.58M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-6.5985
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-9.48%
1M Performance:
-19.86%
6M Performance:
-43.15%
1Y Performance:
+67.61%
1-Day Range:
Value
$17.05
$17.87
1-Week Range:
Value
$17.05
$19.60
52-Week Range:
Value
$7.42
$34.84

Caredx Inc Stock (CDNA) Company Profile

Name
Name
Caredx Inc
Name
Phone
415-287-2300
Name
Address
8000 MARINA BLVD, BRISBANE, CA
Name
Employee
650
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
CDNA's Discussions on Twitter

Compare CDNA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
CDNA
Caredx Inc
17.75 986.58M 312.78M -143.56M 1.22M -2.69
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
497.60 196.14B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.00 150.17B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
419.95 34.36B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
116.98 33.45B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
176.30 31.62B 15.41B 1.37B 2.11B 7.50

Caredx Inc Stock (CDNA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-15-25 Upgrade Wells Fargo Underweight → Equal Weight
Aug-28-24 Initiated Wells Fargo Underweight
Aug-19-24 Upgrade BTIG Research Neutral → Buy
May-13-24 Downgrade Raymond James Outperform → Mkt Perform
May-01-24 Upgrade Craig Hallum Hold → Buy
Nov-09-23 Upgrade Stephens Equal-Weight → Overweight
Aug-15-23 Upgrade Raymond James Mkt Perform → Outperform
May-11-23 Downgrade BTIG Research Buy → Neutral
Mar-07-23 Downgrade Stephens Overweight → Equal-Weight
Mar-03-23 Downgrade Craig Hallum Buy → Hold
Mar-03-23 Downgrade Raymond James Strong Buy → Mkt Perform
Apr-25-22 Initiated Stephens Overweight
Jul-20-21 Resumed BTIG Research Buy
Jun-03-21 Initiated Goldman Buy
Feb-26-21 Downgrade H.C. Wainwright Buy → Neutral
Oct-30-20 Reiterated H.C. Wainwright Buy
Oct-08-20 Reiterated H.C. Wainwright Buy
Oct-02-20 Reiterated H.C. Wainwright Buy
Aug-05-20 Reiterated H.C. Wainwright Buy
Jun-26-20 Initiated BTIG Research Buy
Jun-19-20 Reiterated H.C. Wainwright Buy
Oct-01-19 Resumed Craig Hallum Buy
May-09-19 Upgrade H.C. Wainwright Neutral → Buy
Feb-15-19 Initiated Jefferies Buy
Oct-23-18 Resumed Raymond James Strong Buy
Sep-18-18 Reiterated H.C. Wainwright Neutral
Nov-27-17 Initiated H.C. Wainwright Buy
Jun-14-16 Reiterated Mizuho Buy
Sep-29-15 Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15 Initiated Craig Hallum Buy
Mar-18-15 Reiterated Mizuho Buy
View All

Caredx Inc Stock (CDNA) Latest News

pulisher
Mar 28, 2025

CareDx CFO secures new severance agreement terms By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - Business Wire

Mar 28, 2025
pulisher
Mar 28, 2025

CareDx CFO secures new severance agreement terms - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

CareDx Updates CFO Severance Agreement Amid Leadership Changes - TipRanks

Mar 28, 2025
pulisher
Mar 26, 2025

CareDx Inc (CDNA) Shares Gap Down to $18.22 on Mar 26 - GuruFocus

Mar 26, 2025
pulisher
Mar 20, 2025

CareDx Releases Two Expanded Indications for AlloSure Testing Services - MPO-mag

Mar 20, 2025
pulisher
Mar 19, 2025

SHAREHOLDER ALERT: Kaskela Law LLC Announces Class Action - GlobeNewswire

Mar 19, 2025
pulisher
Mar 17, 2025

Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra

Mar 17, 2025
pulisher
Mar 16, 2025

Trend Tracker for (CDNA) - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 14, 2025

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - PR Newswire

Mar 14, 2025
pulisher
Mar 14, 2025

CareDx Launches Two Expanded Indications for AlloSure Testing Services - Diagnostic and Interventional Cardiology

Mar 14, 2025
pulisher
Mar 14, 2025

CareDx, Inc (NASDAQ:CDNA) Shares Bought by US Bancorp DE - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

CareDx: Some Litigation Clouds Have Cleared - Seeking Alpha

Mar 13, 2025
pulisher
Mar 13, 2025

CareDx director George Bickerstaff sells $367,102 in common stock - Investing.com India

Mar 13, 2025
pulisher
Mar 12, 2025

CareDx Director Makes Significant Stock Sale! - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

CareDx director George Bickerstaff sells $367,102 in common stock By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem - simplywall.st

Mar 11, 2025
pulisher
Mar 11, 2025

Major Breakthrough: CareDx AlloSure Now Covers Infant Heart and Dual-Organ Transplant Testing - Stock Titan

Mar 11, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Has $406,000 Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

HC Wainwright Has Negative Estimate for CareDx Q1 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

(CDNA) On The My Stocks Page - news.stocktradersdaily.com

Mar 05, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Boosts Stake in CareDx, Inc (NASDAQ:CDNA) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

New York State Common Retirement Fund Sells 15,584 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

CareDx (NASDAQ:CDNA) Trading Down 7.9% Following Analyst Downgrade - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

CareDx stock price target cut to $25 at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

CareDx (NASDAQ:CDNA) Price Target Cut to $25.00 by Analysts at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

CareDx stock price target cut to $25 at H.C. Wainwright - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Where CareDx Stands With Analysts - Benzinga

Mar 03, 2025
pulisher
Mar 01, 2025

CareDx, Inc (NASDAQ:CDNA) Shares Sold by ARK Investment Management LLC - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

CareDx (NASDAQ:CDNA) Shares Gap Up Following Strong Earnings - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Decoding CareDx Inc (CDNA): A Strategic SWOT Insight - GuruFocus.com

Mar 01, 2025
pulisher
Mar 01, 2025

CareDx (NASDAQ:CDNA) Upgraded by StockNews.com to "Buy" Rating - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

CareDx, Inc (NASDAQ:CDNA) Q4 2024 Earnings Call Transcript - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Bradley & Co. Private Wealth Management LLC Invests $269,000 in CareDx, Inc (NASDAQ:CDNA) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

CareDx (NASDAQ:CDNA) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Stephens Reaffirms Overweight Rating for CareDx (NASDAQ:CDNA) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

CareDx, Inc. SEC 10-K Report - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

CareDx Inc. Reports Strong Growth and Positive Outlook - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx (NASDAQ:CDNA) Issues Quarterly Earnings Results - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx: Q4 Earnings Snapshot - mySA

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx Inc (CDNA) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Caredx Inc earnings beat by $0.41, revenue topped estimates - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx Announces Fourth Quarter and Full Year 2024 Financial Results - BioSpace

Feb 27, 2025
pulisher
Feb 26, 2025

CareDx Reports Strong 2024 Financial Performance - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: CareDx Q4 2024 beats EPS forecast, stock rises By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: CareDx Q4 2024 beats EPS forecast, stock rises - Investing.com

Feb 26, 2025

Caredx Inc Stock (CDNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$169.20
price up icon 1.12%
$141.41
price down icon 1.76%
diagnostics_research LH
$232.74
price up icon 1.18%
diagnostics_research WAT
$368.57
price up icon 1.77%
diagnostics_research MTD
$1,180.91
price up icon 0.32%
diagnostics_research IQV
$176.30
price down icon 0.61%
Cap:     |  Volume (24h):